APO Research
Talk to an analyst

APO RESEARCH · REPORT

IBS-C Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IBS-C Drug Industry Growth and Trends Forecast to 2032

20 December 202572 pages

Choose your research edition.

Industry ResearchIBS-C Drug Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal IBS-C Drug Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal IBS-C Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IBS-C Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal IBS-C Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global IBS-C Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IBS-C Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IBS-C Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IBS-C Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IBS-C Drug include Nestle, Synergy Pharmaceuticals, Catalent Pharmaceuticals Solutions and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IBS-C Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IBS-C Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IBS-C Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IBS-C Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IBS-C Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IBS-C Drug Market by Company

Nestle

Synergy Pharmaceuticals

Catalent Pharmaceuticals Solutions

Abbott Laboratories

IBS-C Drug Segment by Type

LINZESS (Linaclotide)

Amitiza

Milk of Magnesia

Lactulose

Others

IBS-C Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

IBS-C Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IBS-C Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IBS-C Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IBS-C Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IBS-C Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IBS-C Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of LINZESS (Linaclotide) Table 2. Major Company of Amitiza Table 3. Major Company of Milk of Magnesia Table 4. Major Company of Lactulose Table 5. Major Company of Others Table 6. Global IBS-C Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 8. Global IBS-C Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global IBS-C Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global IBS-C Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 13. Global IBS-C Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global IBS-C Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global IBS-C Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global IBS-C Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 18. North America IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa IBS-C Drug Sales by Type (2021-2026) & (US$ Million) Table 27. IBS-C Drug Industry Trends Table 28. IBS-C Drug Industry Drivers Table 29. IBS-C Drug Industry Opportunities and Challenges Table 30. IBS-C Drug Industry Restraints Table 31. Global IBS-C Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global IBS-C Drug Revenue Market Share by Company (2021-2026) Table 33. Global IBS-C Drug Sales by Company (2021-2026) & (K Units) Table 34. Global IBS-C Drug Sales Share by Company (2021-2026) Table 35. Global IBS-C Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global IBS-C Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global IBS-C Drug Major Company Production Sites and Headquarters Table 38. Global IBS-C Drug Company, Product Type & Application Table 39. Global IBS-C Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global IBS-C Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global IBS-C Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global IBS-C Drug Sales by Region (2021-2026) & (K Units) Table 44. Global IBS-C Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global IBS-C Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global IBS-C Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global IBS-C Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global IBS-C Drug Sales by Region (2027-2032) & (K Units) Table 49. Global IBS-C Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global IBS-C Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global IBS-C Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global IBS-C Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global IBS-C Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 55. Global IBS-C Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global IBS-C Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global IBS-C Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 60. Global IBS-C Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global IBS-C Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global IBS-C Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global IBS-C Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 65. North America IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa IBS-C Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Nestle Company Information Table 75. Nestle Business Overview Table 76. Nestle IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Nestle IBS-C Drug Product Portfolio Table 78. Nestle Recent Development Table 79. Synergy Pharmaceuticals Company Information Table 80. Synergy Pharmaceuticals Business Overview Table 81. Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Synergy Pharmaceuticals IBS-C Drug Product Portfolio Table 83. Synergy Pharmaceuticals Recent Development Table 84. Catalent Pharmaceuticals Solutions Company Information Table 85. Catalent Pharmaceuticals Solutions Business Overview Table 86. Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Catalent Pharmaceuticals Solutions IBS-C Drug Product Portfolio Table 88. Catalent Pharmaceuticals Solutions Recent Development Table 89. Abbott Laboratories Company Information Table 90. Abbott Laboratories Business Overview Table 91. Abbott Laboratories IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Abbott Laboratories IBS-C Drug Product Portfolio Table 93. Abbott Laboratories Recent Development Table 94. North America IBS-C Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 96. North America IBS-C Drug Sales Market Share by Country (2021-2026) Table 97. North America IBS-C Drug Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America IBS-C Drug Sales Market Share Forecast by Country (2027-2032) Table 99. North America IBS-C Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America IBS-C Drug Market Size by Country (2021-2026) & (US$ Million) Table 101. North America IBS-C Drug Market Share by Country (2021-2026) Table 102. North America IBS-C Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America IBS-C Drug Market Share Forecast by Country (2027-2032) Table 104. Europe IBS-C Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 106. Europe IBS-C Drug Sales Market Share by Country (2021-2026) Table 107. Europe IBS-C Drug Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe IBS-C Drug Sales Market Share Forecast by Country (2027-2032) Table 109. Europe IBS-C Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe IBS-C Drug Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe IBS-C Drug Market Share by Country (2021-2026) Table 112. Europe IBS-C Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe IBS-C Drug Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific IBS-C Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific IBS-C Drug Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific IBS-C Drug Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific IBS-C Drug Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific IBS-C Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific IBS-C Drug Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific IBS-C Drug Market Share by Country (2021-2026) Table 122. Asia-Pacific IBS-C Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific IBS-C Drug Market Share Forecast by Country (2027-2032) Table 124. Latin America IBS-C Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 126. Latin America IBS-C Drug Sales Market Share by Country (2021-2026) Table 127. Latin America IBS-C Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America IBS-C Drug Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America IBS-C Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America IBS-C Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America IBS-C Drug Market Share by Country (2021-2026) Table 132. Latin America IBS-C Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America IBS-C Drug Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa IBS-C Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa IBS-C Drug Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa IBS-C Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa IBS-C Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa IBS-C Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa IBS-C Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa IBS-C Drug Market Share by Country (2021-2026) Table 142. Middle East and Africa IBS-C Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa IBS-C Drug Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. IBS-C Drug Distributors List Table 147. IBS-C Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. IBS-C Drug Image Figure 2. Global IBS-C Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IBS-C Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global IBS-C Drug Sales (2021-2032) & (K Units) Figure 5. LINZESS (Linaclotide) Image Figure 6. Global LINZESS (Linaclotide) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Amitiza Image Figure 8. Global Amitiza Sales YoY Growth (2021-2032) & (K Units) Figure 9. Milk of Magnesia Image Figure 10. Global Milk of Magnesia Sales YoY Growth (2021-2032) & (K Units) Figure 11. Lactulose Image Figure 12. Global Lactulose Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global IBS-C Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global IBS-C Drug Market Share by Type 2025 VS 2032 Figure 17. North America IBS-C Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America IBS-C Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe IBS-C Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe IBS-C Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific IBS-C Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific IBS-C Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America IBS-C Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America IBS-C Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa IBS-C Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa IBS-C Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 IBS-C Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global IBS-C Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global IBS-C Drug Market Share by Application 2025 VS 2032 Figure 37. North America IBS-C Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America IBS-C Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe IBS-C Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe IBS-C Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific IBS-C Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific IBS-C Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America IBS-C Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America IBS-C Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa IBS-C Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa IBS-C Drug Sales Market Share in Value by Application in 2025 Figure 47. North America IBS-C Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America IBS-C Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America IBS-C Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America IBS-C Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe IBS-C Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe IBS-C Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe IBS-C Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe IBS-C Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific IBS-C Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific IBS-C Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific IBS-C Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific IBS-C Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America IBS-C Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America IBS-C Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America IBS-C Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America IBS-C Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa IBS-C Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa IBS-C Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa IBS-C Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa IBS-C Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. IBS-C Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. IBS-C Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • LINZESS (Linaclotide)
  • Amitiza
  • Milk of Magnesia
  • Lactulose
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Nestle
  • Synergy Pharmaceuticals
  • Catalent Pharmaceuticals Solutions
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IBS-C Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IBS-C Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IBS-C Drug Market by Type
  6. 1.3.1 LINZESS (Linaclotide)
  7. 1.3.2 Amitiza
  8. 1.3.3 Milk of Magnesia
  9. 1.3.4 Lactulose
  10. 1.3.5 Others
  11. 1.4 Global IBS-C Drug Market Size by Type
  12. 1.4.1 Global IBS-C Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global IBS-C Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global IBS-C Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America IBS-C Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe IBS-C Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific IBS-C Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America IBS-C Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa IBS-C Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IBS-C Drug Industry Trends
  2. 2.2 IBS-C Drug Industry Drivers
  3. 2.3 IBS-C Drug Industry Opportunities and Challenges
  4. 2.4 IBS-C Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IBS-C Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by IBS-C Drug Sales (2021-2026)
  3. 3.3 Global Top Players by IBS-C Drug Price (2021-2026)
  4. 3.4 Global IBS-C Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IBS-C Drug Major Company Production Sites & Headquarters
  6. 3.6 Global IBS-C Drug Company, Product Type & Application
  7. 3.7 Global IBS-C Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IBS-C Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IBS-C Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IBS-C Drug Tier 1, Tier 2, and Tier 3
4 IBS-C Drug Regional Status and Outlook
  1. 4.1 Global IBS-C Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IBS-C Drug Historic Market Size by Region
  3. 4.2.1 Global IBS-C Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IBS-C Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IBS-C Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IBS-C Drug Forecasted Market Size by Region
  7. 4.3.1 Global IBS-C Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IBS-C Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IBS-C Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IBS-C Drug by Application
  1. 5.1 IBS-C Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global IBS-C Drug Market Size by Application
  6. 5.2.1 Global IBS-C Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global IBS-C Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global IBS-C Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America IBS-C Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe IBS-C Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific IBS-C Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America IBS-C Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa IBS-C Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Nestle
  2. 6.1.1 Nestle Company Information
  3. 6.1.2 Nestle Business Overview
  4. 6.1.3 Nestle IBS-C Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Nestle IBS-C Drug Product Portfolio
  6. 6.1.5 Nestle Recent Developments
  7. 6.2 Synergy Pharmaceuticals
  8. 6.2.1 Synergy Pharmaceuticals Company Information
  9. 6.2.2 Synergy Pharmaceuticals Business Overview
  10. 6.2.3 Synergy Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Synergy Pharmaceuticals IBS-C Drug Product Portfolio
  12. 6.2.5 Synergy Pharmaceuticals Recent Developments
  13. 6.3 Catalent Pharmaceuticals Solutions
  14. 6.3.1 Catalent Pharmaceuticals Solutions Company Information
  15. 6.3.2 Catalent Pharmaceuticals Solutions Business Overview
  16. 6.3.3 Catalent Pharmaceuticals Solutions IBS-C Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Catalent Pharmaceuticals Solutions IBS-C Drug Product Portfolio
  18. 6.3.5 Catalent Pharmaceuticals Solutions Recent Developments
  19. 6.4 Abbott Laboratories
  20. 6.4.1 Abbott Laboratories Company Information
  21. 6.4.2 Abbott Laboratories Business Overview
  22. 6.4.3 Abbott Laboratories IBS-C Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Laboratories IBS-C Drug Product Portfolio
  24. 6.4.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America IBS-C Drug Sales by Country
  2. 7.1.1 North America IBS-C Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IBS-C Drug Sales by Country (2021-2026)
  4. 7.1.3 North America IBS-C Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America IBS-C Drug Market Size by Country
  6. 7.2.1 North America IBS-C Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IBS-C Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America IBS-C Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IBS-C Drug Sales by Country
  2. 8.1.1 Europe IBS-C Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IBS-C Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe IBS-C Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IBS-C Drug Market Size by Country
  6. 8.2.1 Europe IBS-C Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IBS-C Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe IBS-C Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IBS-C Drug Sales by Country
  2. 9.1.1 Asia-Pacific IBS-C Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IBS-C Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IBS-C Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IBS-C Drug Market Size by Country
  6. 9.2.1 Asia-Pacific IBS-C Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IBS-C Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IBS-C Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IBS-C Drug Sales by Country
  2. 10.1.1 South America IBS-C Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IBS-C Drug Sales by Country (2021-2026)
  4. 10.1.3 South America IBS-C Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America IBS-C Drug Market Size by Country
  6. 10.2.1 South America IBS-C Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IBS-C Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America IBS-C Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IBS-C Drug Sales by Country
  2. 11.1.1 Middle East and Africa IBS-C Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IBS-C Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IBS-C Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IBS-C Drug Market Size by Country
  6. 11.2.1 Middle East and Africa IBS-C Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IBS-C Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IBS-C Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IBS-C Drug Value Chain Analysis
  2. 12.1.1 IBS-C Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IBS-C Drug Production Mode & Process
  7. 12.2 IBS-C Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IBS-C Drug Distributors
  10. 12.2.3 IBS-C Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst